Pfizer Told To Conduct Phase IV Trial of Abrocitinib in Indian Adolescents with Atopic Dermatitis Parthika Patel4 July 2025 3:00 PM ISTNew Delhi: In a recent regulatory development, the Subject Expert Committee (SEC) under the Dermatology and Allergy division of the Central Drugs...
Submit Full Adverse Event Data from Lenvatinib Phase IV Liver Cancer Trial: CDSCO Panel To Eisai Pharma Parthika Patel4 July 2025 1:00 PM ISTNew Delhi: In a recent regulatory review, the Subject Expert Committee (SEC) under the Oncology division of the Central Drugs Standard Control...
High-Alcohol Medicinal Preparations to Come Under Schedule H1: Govt Panel Approves Rule Change Farhat Nasim4 July 2025 12:00 PM ISTNew Delhi: The Drugs Consultative Committee (DCC) has agreed to amend the Drugs Rules, 1945 to regulate the alcohol content in tinctures and other...
Delhi HC Flags Off-Label Use of Diabetes Drugs for Weight Loss, Seeks CDSCO Report Farhat Nasim3 July 2025 9:27 PM ISTNew Delhi: The Delhi High Court has directed the Central Drugs Standard Control Organisation (CDSCO) and the Drug Controller General of India (DCGI)...
Sun Pharma Gets CDSCO Panel Go-Ahead to Manufacture, Market Relugolix, Estradiol, Norethindrone Acetate FDC Parthika Patel2 July 2025 5:01 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Reproductive division of the Central Drugs Standard Control Organization (CDSCO) has...
DCC Recommends Licensing, Labelling Restrictions on Anti-TB Drugs to Curb Private Market Misuse Farhat Nasim1 July 2025 11:07 PM ISTNew Delhi: In a move to curb potential misuse of critical tuberculosis medications, the Drugs Consultative Committee (DCC) has recommended that...
Hetero Labs' Acarbose-Sitagliptin-Metformin FDC Rejected by CDSCO Panel Over GI Risk Written By Dr. Divya Colin30 Jun 2025 5:45 PM ISTNew Delhi: In a setback to Hetero Labs Limited, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organisation...
CDSCO Clears Abbott's phase IV Trial Of Dydrogesterone MR Tablet Parthika Patel30 Jun 2025 2:53 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Reproductive division of the Central Drugs Standard Control Organization (CDSCO) has approved...
Intas Gets SEC Nod to Import, Market Anti-Cancer Drug Serplulimab, Phase IV Trial Mandated Written By Dr. Divya Colin29 Jun 2025 1:00 PM ISTNew Delhi: Intas Pharmaceutical has received approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Abbott Gets SEC Nod to Market Chlordiazepoxide Tablets for Anxiety, Alcohol Withdrawal Written By Dr. Divya Colin28 Jun 2025 7:44 PM ISTNew Delhi: Abbott Healthcare has received approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Pfizer Gets CDSCO Panel Nod to Conduct Phase IIIb Trial of Rimegepant for Menstrual Migraine Parthika Patel28 Jun 2025 7:23 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organisation (CDSCO) has granted Pfizer Limited...
Akums Gets CDSCO Panel Nod for BE Study of Rizatriptan-Meloxicam FDC, Told to Revise Phase III Protocol Written By Dr. Divya Colin27 Jun 2025 11:07 PM ISTNew Delhi: In response to the proposal presented by the Akums Drugs & Pharmaceuticals along with BE and Phase III clinical trial protocol of the...
